Coron Pharmaceuticals: Brivaracetam orally disintegrating film obtained drug registration approval.

Kolon Pharmaceutical announced that its chemical drug "Brexpiprazole orally disintegrating film" has recently received drug registration approval from the National Medical Products Administration. Brexpiprazole orally disintegrating film is a new improved drug independently developed by the company. Compared to tablets, it has the advantages of convenient consumption without water, quick dissolution in the mouth within seconds, easy to swallow, etc., which can effectively reduce the risk of drug hiding for patients with schizophrenia.